gaithersburg semaglutide & tirzepatide F.D.A. Approves New Obesity Drug That Will Compete With Wegovy Semaglutide vs. Tirzepatide for Weight

Currently recommended pharmacotherapies in the practice guidelines from US, Europe, and Japan Evidence-based practice guidelines for the management of NASH/NAFLD were published by the American Association for the Study of Liver Disease (AASLD) in 2012 [5], the Japan Society of Gastroenterology (JSG)Japan Society of Hepatology (JSH) in 2014 [6], and the European Association for the Study of the Liver (EASD)European Association for the Study of Diabetes (EASL)European Association for the Study of Obesity (EASO) in 2016 [7]

V.SignorC.da Silva BernardiJ.et al (2019)

[2] Beyond skin: pulmonary fibrosis

GLP-1s support a healthier approach by promoting gradual weight loss, which is more likely to be maintained long-term

doi: [Springer] 55

doi: 10.1136/jmg.2004.029439 125 LeeT